GELAD Chemotherapy and Sandwiched Radiotherapy in the Treatment of Stage IE/IIE Natural Killer/T-cell Lymphoma
Status:
Completed
Trial end date:
2021-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of gemcitabine, etoposide,
pegaspargase and dexamethasone (GELAD) chemotherapy and sandwiched radiotherapy as first-line
treatment in patients with de novo stage IE/IIE extranodal natural killer/T-cell lymphoma,
nasal type.
Phase:
N/A
Details
Lead Sponsor:
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine